Sign in
8-K

Current Report

Taysha Gene Therapies, Inc. Filed Acc 0001193125-20-285213

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d202550d8k.htm…